Abstract. Notch signaling pathway maintains stem cells through transcriptional activation of HES/HEY family members to repress tissue-specific transcription factors. Here, comparative integromic analyses on HES/HEY family members were carried out. HES3 gene encodes two isoforms due to alternative promoters. Complete coding sequence of HES3 variant 2 was determined by curating CX755241.1 EST. Refined phylogenetic analysis using HES3 variant 2 instead of variant 1 revealed that mammalian bHLH transcription factors with Orange domain were grouped into HES subfamily (HES1, HES2, HES3, HES4, HES5, HES6, HES7) and HEY subfamily (HEY1, HEY2, HEYL, HESL/HELT, DEC1/ BHLHB2, DEC2/BHLHB3). Eight amino-acid residues were added to the C-terminal WRPW motif in human HES3 due to lineage specific T to G nucleotide change at stop codon of chimpanzee, rat, and mouse HES3 orthologs. HES1 and HES3 were expressed in undifferentiated embryonic stem (ES) cells. HES1 was also expressed in fetal tissues, and regenerating liver. HES1, HEY1 and HEY2 were expressed in endothelial cells. HES1, HES4 and HES6 were expressed in gastric cancer, HES1 and DEC1 in pancreatic cancer, HES1, HES2, HES4, HES6 and DEC2 in colorectal cancer. HES6 was also expressed in other tumors, such as brain tumors, melanoma, small cell lung cancer, retinoblastoma, ovarian cancer, and breast cancer. Double NANOG-binding sites, CSL/ RBPSUH-binding site and TATA-box in HES1 promoter, NANOG-, SOX2-, POU5F1/OCT3/OCT4-binding sites and TATA-box in HES3 promoter, double CSL-binding sites in HES5 promoter, SOX2-, POU-binding sites and TATA-box in HES6 promoter, and CSL-binding site in HEY1, HEY2 and HEYL promoters were evolutionarily conserved. However, double CSL-binding sites in mouse Hes7 promoter were not conserved in human HES7 promoter. Together these facts indicate that HES1 and HES3 were target genes of the ES cellspecific network of transcription factors, and that HES1, HES5, HEY1, HEY2 and HEYL were target genes of Notch signaling pathway.
Introduction
Notch signaling pathway is implicated in self-renewal of stem cells and cell-fate determination of progenitors (1) (2) (3) (4) . Notch signaling pathway constitutes the stem cell signaling network together with WNT signaling pathway (5-9), FGF signaling pathway (10) (11) (12) (13) (14) , BMP signaling pathway (15) (16) (17) , and Hedgehog signaling pathway (18) (19) (20) (21) (22) (23) (24) . Stem cell signaling network is implicated in embryogenesis and maintenance of adult tissue homeostasis. Dysregulation of the stem cell signaling network leads to pathological conditions, such as congenital disorders, metabolic syndrome, and cancer (25) (26) (27) .
JAG1, JAG2, DLL1, DLL3 and DLL4 are typical transmembrane-type Notch ligands sharing the common domain architecture with extracellular DSL domain and EGF-like repeats (28) (29) (30) (31) , while NOTCH1, NOTCH2, NOTCH3 and NOTCH4 are Notch family receptors sharing the common domain architecture with extracellular EGF-like repeats, Lin12/Notch repeats, cytolasmic RAM23 domain, Ankyrin repeats, and PEST domain (32, 33) . Lignand-binding induces the γ-secretase-mediated processing of Notch family receptors to release Notch intracellular domain (NICD) for its interaction with CSL (RBPSUH) transcription factor (34) . MAML1, MAML2 and MAML3 are Mastermind family coactivators (35) associating with the CSL-NICD complex to activate the transcription of Notch target genes (1-4).
Notch target genes HES1 and HES5 encode HES/HEY family of transcription factors with basic helix-loop-helix (bHLH) domain and Orange domain (36) (37) (38) (39) . bHLH domain is implicated in the DNA-binding and dimerization, and Orange domain in the selection of bHLH heterodimer partner (39) . Because HES1 and HES5 repress the transcription of tissuespecific transcription factors, canonical Notch signaling activation results in the maintenance of stem or progenitor cells through the inhibition of differentiation (1) (2) (3) (4) .
Functional and phenotypical analyses on HES/HEY family members in mouse and zebrafish experimental system have been reported (reviewed in ref. 39); however, biological function of human HES/HEY family members remained relatively unclear. Here, integrative genomic analyses on HES/HEY family members were carried out to elucidate the expression profile and transcriptional mechanisms of human HES/HEY family members.
Materials and methods
Comparative genomics analyses. Genome sequences of human and mouse HES/HEY family members were searched for using the BLAST programs as previously described (40) (41) (42) . Exonintron boundaries were determined based on the consensus sequence of exon-intron junctions ('gt ..... ag' rule of intronic sequence) and codon usage within the coding region. Conserved transcription factor-binding sites within promoter regions were then searched for based on the Match program, Genetyx program, and manual curation as previously described (43) (44) (45) In silico expression analyses. Expressed sequence tags (ESTs) derived from human HES/HEY family members were searched for using the BLAST programs as previously described (48) (49) (50) 
Results
Complete coding sequence of human HES3. We have previously reported the coding sequence of human HES3 (37); however, 5'-UTR and transcription start site of HES3 remained unclear. Human HES3 RefSeq NM_001024598.1 was an artificial prediction with aberrant 5'-splicing site for exon 2 and aberrant splicing out within exon 4. We found that CX755241.1, CN370500.1, and CN413592.1 ESTs were derived from the human HES3 gene. The first exon of human HES3 transcript for CX755241.1, CN370500.1 and CN413592.1 ESTs was distinct from that of human HES3 RefSeq NM_001024598.1. Hirata et al reported that mouse Hes3 gene encodes two splicing variants due to alternative promoters (47) . Human HES3 RefSeq NM_001024598.1 corresponded to mouse Hes3 splicing variant 1 with exon 1a, while human HES3 ESTs CX755241.1, CN370500.1 and CN413592.1 corresponded to mouse Hes3 splicing variant 2 with exon 1b.
Three nucleotide substitutions were identified in CX755241.1 EST, compared with other human HES3 ESTs and human genome sequence. In addition, the transcription start site of the human HES3 gene was predicted to be located at least 9-bp upstream position of CX755241.1 5'-end based on the comparison of human HES3 and mouse Hes3 genes. Complete coding sequence of human HES3 splicing variant 2 was determined by curating the points mentioned above (Fig. 1A) . Nucleotide position 7-633 was the coding region of human HES3 splicing variant 2. Human HES3 variant 2 was a 208-amino-acid protein, which was longer than human HES3 variant 1 in the N-terminal region by 22 amino acids (Fig. 1A) .
Comparative proteomics on mammalian HES/HEY family members. Orthologs of human HES/HEY family genes, except HES4, were identified within the mouse genome. Human HES/HEY family consists of 13 members, while mouse Hes/ Hey family consists of 12 members. We previously reported phylogenetic analysis on HES/HEY family members using human HES3 variant 1 and mouse Hes3 variant 1 (46) . Here, refined phylogenetic analysis on HES/HEY family members was carried out using human HES3 variant 2 and mouse Hes3 variant 2 ( Fig. 2A) . HES1, HES2, HES3, HES4, HES5, HES6 and HES7 were classified as the HES subfamily, while HEY1, HEY2, HEYL, HESL, DEC and DEC2 were classified as the HEY subfamily. HES subfamily members share the common domain architecture of bHLH domain, Orange domain and WRPW motif. HEY subfamily members share the common domain architecture of bHLH domain and Orange domain; however, the WRPW motif was absent in HEY subfamily members. HES1, HEY1 and HEYL orthologs were well conserved between human and mouse, while HES2 and HES3 orthologs were divergent ( Fig. 2A) .
Alignment of human HES3 and mouse Hes3 revealed that eight amino-acid residues were added to the C-terminal WRPW motif in human HES3 (Fig. 1B) . Coding region of human HES3 transcript was elongated in the 3'-position by 24 bp compared to that of mouse Hes3 transcript due to the T to G nucleotide substitution at the position corresponding to the stop codon of mouse Hes3 transcript. The T to G nucleotide substitution in the human HES3 gene was not detected in the chimpanzee, mouse, and rat HES3 orthologs (Fig. 1B) . These facts indicate that the 8-amino-acid elongation at the C-terminus of human HES3 was caused by a nucleotide substitution specific to the human lineage.
Expression profile of human HES/HEY family members.
In silico expression analyses were carried out to investigate the expression profile of human HES/HEY family transcripts (Fig. 2B) . HES1 mRNA was expressed in undifferentiated ES cells, fetal tissues, retina, endothelial cells, pancreatic islet, regenerating liver, and gastroenterological tumors, such as gastric, pancreatic, and colorectal cancer. HES2 mRNA was expressed in placenta, trachea, tongue tumor, and colorectal cancer. HES3 mRNA was preferentially expressed in undifferentiated ES cells. HES4 mRNA was expressed in fetal brain, hypothalamus, and gastroenterological tumors. HES5 mRNA was expressed in hypothalamus, and brain tumors. HES6 mRNA was expressed in a variety of tumors, such as brain tumors, melanoma, small cell lung cancer, retinoblastoma, ovarian, gastric, colorectal, and breast cancer. HES7 mRNA was expressed in cervical cancer. HEY1 mRNA was expressed in a variety of neural tissues, such as hippocampus, amygdala, substantia nigra, pineal gland, and also in endothelial cells, and brain tumors. HEY2 mRNA was expressed in neural tissues, and endothelial cells. HEYL mRNA was expressed in neural tissues, pancreatic islet, and rhabdomyosarcoma. HESL mRNA was expressed in ovarian fibrotheoma. DEC1 mRNA was expressed in ES cell-derived embryoid body, neural tissues, pancreatic islet, pancreatic cancer, melanoma, cervical cancer, head and neck cancer. DEC2 mRNA was expressed in neural tissues, germinal center B cells, multiple sclerosis, brain tumors, parathyroid tumors, and colorectal cancer. (Fig. 3A) . Mouse Hes1, Hes2, Hes3, Hes5, Hes6 , Hes7, Hey1, Hey2, Heyl, Hesl, Dec1 and Dec2 genes were located within CT030736.8, AL772240.7, AL611985.22, BX004788.7, AC110510.6, AL645527.20, AC132225.3, AC125532.3, AL606934.12, AC156551.5, AC153593.4, and AC144936.4 genome sequences, respectively.
Transcription factor-binding sites conserved between human and mouse HES/HEY orthologs were then searched for (Fig. 3A) . Double NANOG-binding sites, CSL-binding site, and TATA-box in human HES1 promoter were conserved in mouse Hes1 promoter (Fig. 3B) . NANOG/SOX2-binding site, POU5F1 (OCT3/4)-binding site, and TATA-box in human HES3 promoter were conserved in mouse Hes3 promoter (Fig. 1C) . Double CSL-binding sites in human HES5 promoter were conserved in mouse Hes5 promoter (Fig. 3C ). SOX2-binding site, POU5F1-binding site and TATA-box in human HES6 promoter were conserved in mouse Hes6 promoter (Fig. 3D) . Although double CSL-binding sites in mouse Hes7 promoter was not conserved in human HES7 promoter, CSLbinding site in human HEY1, HEY2, and HEYL promoters was evolutionarily conserved (Fig. 3A) .
Discussion
Complete coding sequence of HES3 variant 2 was determined by curating CX755241.1 EST (Fig. 1A) . Human HES3 variant 2 was longer than human HES3 variant 1 in the Nterminal region by 22 amino acids (Fig. 1A) . Mouse Hes3 variant 2 with the basic region binds to genomic DNA, but mouse Hes3 variant 1 without the basic region does not bind to genomic DNA (47) . HES3 orthologs encode two isoforms with N-terminal divergence due to alternative promoters.
Refined phylogenetic analysis using HES3 variant 2 instead of variant 1 revealed that mammalian bHLH transcription factors with Orange domain were grouped into HES subfamily (HES1, HES2, HES3, HES4, HES5, HES6, HES7) and HEY subfamily (HEY1, HEY2, HEYL, HESL/HELT, DEC1/ BHLHB2, DEC2/BHLHB3) ( Fig. 2A) .
Phylogenetic analysis also indicated that HES3 orthologs were relatively divergent among the HES/HEY family ( Fig. 2A) . Comparative genomics revealed that eight aminoacid residues were added to the C-terminal WRPW motif in human HES3 due to lineage specific T to G nucleotide change at the position corresponding to the stop codon of chimpanzee, rat, and mouse HES3 orthologs (Fig. 1B) . These facts indicated that protein evolution occurred in human HES3.
HES3 expression was restricted to undifferentiated ES cells, while HES1 expression was detected in undifferentiated ES cells as well as in fetal tissues, adult tissues, and gastrointestinal tumors (Fig. 2B) . NANOG-, SOX2-, POU5F1-binding sites, and TATA-box in human HES3 promoter were conserved in the mouse Hes3 promoter (Fig. 1C) . Double NANOG-binding sites, CSL-binding site, and TATA-box in human HES1 promoter were conserved in the mouse Hes1 promoter (Fig. 3B) . HES1 and HES3 were transcribed in undifferentiated human ES cells due to ES cell-specific network of transcription factors, while HES1 was also transcribed in fetal and adult tissues due to Notch signaling activation.
HES1, HES4, HES5, HES6, HEY1, HEY2, HEYL, DEC1, and DEC2 were expressed in neural tissues. HES4, HES5, and HES6 were preferentially expressed in hypothalamus, while HEY1 and DEC2 in hippocampus. Regional preferentiality of HES/HEY family members within human brain was clarified using in silico expression analyses in this study.
CSL-binding sites within HES1, HES5, HEY1, HEY2, and HEYL promoters were evolutionarily conserved; however, those within HES7 promoter were not conserved (Fig. 3A) . Because canonical Notch signaling induces the transcriptional activation of target genes through the MAML-NICD-CSL transcriptional complex (1-4) , expression of HES1, HEY1 and HEY2 in endothelial cells indicate the implication of the Notch signaling pathway in angiogenesis.
HES1 transcription is oscillated in many cell types, such as fibroblasts, myoblasts, neuroblasts, and mesenchymal stem cells (51, 52) . Human HES1 is oscillated with a period of 5 h, while mouse Hes1 is oscillated with a period of 2 h (52). After HES1 transcription and translation, HES1 protein represses the transcription of HES1 mRNA in cell autonomous manner based on the negative autoregulation (39) .
HES1, HES4 and HES6 were expressed in gastric cancer; HES1 and DEC1 in pancreatic cancer; HES1, HES2, HES4, HES6 and DEC2 in colorectal cancer (Fig. 2B) . HES6 was also expressed in other tumors, such as brain tumors, melanoma, small cell lung cancer, retinoblastoma, ovarian cancer, and breast cancer (Fig. 2B) . HES1 expression in gastroenterological tumors is due to Notch signaling activation, and HES6 expression in tumors is partly due to SOX-POU transctiptional complex (Fig. 3) . Because HES6 was expressed in a variety of tumors, further investigation on HES6 could lead to better understanding of carcinogenesis, and development of novel diagnostics or therapeutics for human cancer in various tissues.
Integrative genomic analyses on the HES/HEY family revealed that HES1 and HES3 were target genes of the ES cell-specific network of transcription factors, and that HES1, HES5, HEY1, HEY2 and HEYL were target genes of the Notch signaling pathway.
